Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Shares Outstanding (2009 - 2025)

Grifols' (GRFS) quarterly Shares Outstanding (Entity) came in at $680.5 million in Q4 2025, little changed YoY from $679.7 million in Q4 2024, and little changed on a QoQ basis from $679.7 million in Q4 2024.

Grifols (GRFS) Shares Outstanding (2009 - 2025) Analysis & Trends

Grifols (GRFS) has 17 years of Shares Outstanding (Entity) data on file, last reported at $680.5 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) changed 0.12% year-over-year to $680.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $680.5 million (changed 0.12% YoY) and the FY2025 annual result came in at $680.5 million, changed 0.12% from the prior year.
  • Shares Outstanding (Entity) steadied at $680.5 million in Q4 2025, from $679.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $681.6 million in Q4 2021 to a low of $679.7 million in Q4 2024.
  • A 5-year average of $680.3 million and a median of $679.8 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) slipped 0.58% — and 2025, when it grew 0.12%.
  • Tracing GRFS's Shares Outstanding (Entity) over 5 years: stood at $681.6 million in 2021, then fell by 0.26% to $679.8 million in 2022, then declined by 0.01% to $679.8 million in 2023, then decreased by 0.01% to $679.7 million in 2024, then gained by 0.12% to $680.5 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $680.5 million (Q4 2025), $679.7 million (Q4 2024), and $679.8 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 2.41 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 1.77 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 1.91 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 1.55 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 1.24 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 5.70 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 2.03 Bn
10 Grifols 5.45 Bn 4.45 Bn - 680.51 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 680.51 Mn
Dec 31, 2024 679.67 Mn
Dec 31, 2023 679.76 Mn
Dec 31, 2022 679.81 Mn
Dec 31, 2021 681.56 Mn
Dec 31, 2020 685.52 Mn
Sep 30, 2020 685.12 Mn
Mar 31, 2020 685.12 Mn
Dec 31, 2019 685.12 Mn
Sep 30, 2019 684.71 Mn
Mar 31, 2019 684.71 Mn
Dec 31, 2018 684.71 Mn
Sep 30, 2018 684.20 Mn
Jun 30, 2018 684.20 Mn
Mar 31, 2018 684.20 Mn
Dec 31, 2017 684.20 Mn
Jun 30, 2017 683.23 Mn
Mar 31, 2017 683.23 Mn
Dec 31, 2016 683.23 Mn
Sep 30, 2016 683.55 Mn